The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Consolidation of ownership of Irisium Ltd

17 Apr 2020 07:00

RNS Number : 9548J
KRM22 PLC
17 April 2020
 

KRM22 plc

 

("KRM22" or the "Company")

 

Consolidation of ownership of Irisium Ltd

 

 

KRM22 plc, (AIM: KRM) the technology and software investment company focused on risk management for capital markets, is pleased to announce that it has come to an agreement to acquire the remaining 40% stake in Irisium Ltd ("Irisium") from Cinnober Financial Technology AB ("Cinnober"), which the Company does not already own (the "Transaction") for a £0.55m convertible loan note. Nasdaq acquired Cinnober in 2019.

 

Irisium provides a turnkey market surveillance system that provides customised, market-specific alerts, tailored reports, and integrated case management to make trade surveillance efficient and straightforward. In addition to traditional market abuse scenarios, Irisium monitors high frequency trading, abusive trading patterns and entity relationships. Since the initial investment by the Company, and in addition to enhancing the Irisium market surveillance platform, the Company has successfully integrated it into the Global Risk Platform and is integrating it into the Enterprise Risk Cockpit.

 

Background to the Transaction

The Company originally acquired a 60% stake in Irisium on 5 June 2018 for a cash consideration of £1.7m. In addition, KRM22 and Cinnober (together the "Parent Companies"), provided a total debt facility (the "Debt Facility") to Irisium of £2.7m proportionate to each Parent Company's stake in Irisium on that date.

 

Under the terms of the Transaction, a total of £2.9m in debt (loans advanced to Irisium under the terms of the Debt Facility and accrued interest) together with £0.3 of Irisium other liabilities due to the Parent Companies, has been converted into ordinary shares in Irisium immediately prior to the Company consolidating its ownership of Irisium.

 

On completion of the debt to equity conversion in Irisium, the Company immediately acquired the remaining 40% stake in Irisium for a total consideration of £0.55m payable to Cinnober by way of a convertible loan note (CLN) provided by KRM22 to Cinnober. The CLN is for a one-year term and can be satisfied by either the allotment and issue of ordinary shares of the Company by no later than 31 July 2020 or settled by cash at any point in the CLN term, at the Company's sole discretion. The number of ordinary shares to be allotted to Cinnober shall be equal to £0.55m divided by £0.48 or the price at which KRM22 allots shares on any placement concluded before 31 July 2020. The interest rate payable on the CLN is 8 per cent. per annum payable quarterly. Cinnober is currently a 5.71% shareholder of KRM22. No cash consideration is payable upon announcing so is entirely cash neutral to the Company, other than future interest payments.

 

Benefits of the Transaction

The consolidation of the remaining stake in Irisium will provide the Company with full control over Irisium and allow complete integration with KRM22. The Transaction will immediately remove £0.7m of debt and liabilities from the Group's consolidated balance sheet and £1.3m of debt from the consolidated balance sheet, should the CLN is satisfied by shares, at the Company's sole discretion.

 

Acquisition Financials

Irisium is currently generating £1.6m annualised recurring revenue. For the full financial year to 31 December 2018, it achieved revenue of £1.3m and a loss before tax of £2.2m.

 

Keith Todd CBE, Executive Chairman and Chief Executive Officer of KRM22 plc commented:

 

"The transaction is a natural consequence following Nasdaq's acquisition of Cinnober. It will allow a tighter integration with the core KRM22 Global Risk Platform accelerating the customer benefits from having one platform for market risk and market surveillance."

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne/ Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRIFMLTMTBBBLM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.